Loading organizations...
§ Private Profile · Chaoyang, Liaoning, China
Developer of innovative immune cell therapeutic drugs for cancer treatment.
Juventas has raised $78.7M across 2 funding rounds.
Juventas has raised $78.7M in total across 2 funding rounds.
Juventas has raised $78.7M across 2 funding rounds. Most recently, it raised $64.2M Series C in October 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Oct 25, 2021 | $64.2M Series C | CICC Capital | — | Announced |
| Jul 9, 2019 | $14.5M Series A | — | — | Announced |
Juventas has raised $78.7M in total across 2 funding rounds.
Juventas's investors include CICC Capital.